STAT July 11, 2024
Pfizer said Thursday that it plans to advance a new, once-a-day formulation of its experimental obesity drug danuglipron, meant to be a pill version in the same class as popular injections like Wegovy and Zepbound.
But analysts said that the move represented a hedged bet, as Pfizer is adding yet another preliminary study before beginning larger clinical trials that could eventually result in the medicine’s approval.
The medicine had at one point been a key focus for...
Today's Sponsors
Today's Sponsor